Opinions

Pages

Displaying 41 - 50 of 2943
Ongoing (updated on 07/12/2023)
Reference: 
ECO/612-EESC-2023-2023-00848
Plenary session: 
583 -
Dec 13, 2023 Dec 14, 2023

One of the main conclusions of the 8th Cohesion Report is that although cohesion and convergence among regions in the European Union has improved, there are still remaining gaps especially in less developed regions related with their territorial characteristics. EU islands, mountain areas and sparsely populated areas still face many challenges on their growth and income and disparities exist.

In these regions, there are still a lot of gaps in terms of employment and investment, social exclusion is evident and gender disparities have not diminished.

EESC section opinion: Main challenges faced by EU islands, and mountainous and sparsely populated areas

Ongoing (updated on 07/12/2023)
Reference: 
REX/569-EESC-2023
Plenary session: 
583 -
Dec 13, 2023 Dec 14, 2023

Climate diplomacy frames climate change as an external action policy topic and highlights the need to integrate climate objectives and address climate related risks at the highest diplomatic level and across all policy areas. Through this opinion we build on our previous work in this area and also explore practical aspects of the EU climate diplomacy.

EESC section opinion: EU Climate Diplomacy

Ongoing (updated on 07/12/2023)
Reference: 
CCMI/212-EESC-2023
Plenary session: 
583 -
Dec 13, 2023 Dec 14, 2023

The Covid 19-pandemic has drawn attention to the role of the pharmaceutical industry and to production, availability and affordability of medicines and medicinal products on the European market.

Dependency on critical ingredients, such as active pharmaceutical ingredients (APIs), became obvious when China and India limited exports. According to current data, up to 80% of APIs used in Europe and about 40% of finished medicines sold in Europe come from China or India. The European Union's increasing dependence on API supplies has led to a partial loss of capability to manufacture active substances independently, which poses a potential threat to public health in the countries of the European Union.

EESC section opinion: Securing Europe’s medicine supply: envisioning a Critical Medicines Act

Ongoing (updated on 07/12/2023)
Reference: 
CCMI/216-EESC-2023
Plenary session: 
583 -
Dec 13, 2023 Dec 14, 2023

The Commission’s aim for this non-legislative initiative is to “propose tools on developing open human-centric virtual worlds,” according to the 2023 work program .

EESC section opinion: Initiative on virtual worlds

Pages